glp 1 drugs liver damage GLP-1 Receptor Agonists in Non-Alcoholic Fatty Disease: Current Evidence and Future Perspectives Therapeutic Mechanisms and Clinical Effects

10.1016/j.trsl.2012.10.006 34 MarioG.Niso-SantanoM.BaehreckeE

Over a 16-week protocol, that is less than 20 minutes of total time in exchange for a complete, analyzable research record

5.3 Exercise regulates exerkines expression Exerkines are bioactive molecules secreted by exercise-stimulated tissues such as skeletal muscle, adipose tissue, liver, brain, and other organs, including myokines, cardiokines, hepatokines, adipokines, neurokines, lactate, and miRNAs

Targeting the gut-liver axis in liver disease

I have my sensitive clients start off with half a recommended dose of Category 1, the most widely available type of probiotic